FDA Systems-Based Inspection Approach To Be Expanded By Early 2002
Executive Summary
FDA's systems-based inspection program could be expanded nationwide at the beginning of 2002, CDER Office of Compliance Division of Manufacturing & Product Quality Director Joseph Famulare told the Regulatory Affairs Professionals Society meeting in Baltimore, Md. Nov. 6
You may also be interested in...
Therapeutic Biologic GMP Inspections To Become “More Systems-Based”
Therapeutic biologics manufacturing compliance inspections will move toward the systems-based approach used by the Center for Drug Evaluation & Research, Office of Regulatory Affairs Regional Operations Director Deborah Ralston said
Therapeutic Biologic GMP Inspections To Become “More Systems-Based”
Therapeutic biologics manufacturing compliance inspections will move toward the systems-based approach used by the Center for Drug Evaluation & Research, Office of Regulatory Affairs Regional Operations Director Deborah Ralston said
FDA GMP Plan Stresses Consistency; Systems Approach Ratified By Crawford
FDA will work with an outside consultant to help increase the consistency of pre-approval and post-approval manufacturing oversight